The Challenge of Change - Managing Excipients Control
Colorcon
19-Aug-2004 - In-Pharmatechnologist's periodic round-up of personnel moves in the pharmaceutical sector includes a change in leadership at the Association of the British Pharmaceutical Industry and a new managing director at tabletting and tooling company I Holland.
17-Aug-2004 - Israeli generics and active pharmaceutical ingredients (API) company Teva Pharmaceutical Industries announced yet another acquisition earlier today, this time for Pfizer's Italian generic pharmaceutical marketing company Dorom.
12-Aug-2004 - Fisher Scientific has completed its €3bn merger with Apogent Technologies, continuing an acquisitive period which has seen it become one of the top companies in the market for research tools.
12-Aug-2004 - China has launched a formal anti-dumping investigation into imports of benzofuranol - used as an ingredient in medicines and some pesticides - from Japan, the EU, and the US.
12-Aug-2004 - German biotech company Evotec OAI boosted its second quarter revenues by 18 per cent to €17 million, despite the difficult operating environment for companies supplying drug discovery technologies, continuing its recovery from a weak first quarter.
04-Aug-2004 - Germany's mg technologies has completed the sale of Dynamit Nobel's five business units on schedule at the end of July, marking its exit from the fine chemicals and ingredients sector.
02-Aug-2004 - Life sciences company Tepnel has signed a conditional agreement to acquire OpiSAS' (Opi) subsidiary Diaclone Research, a company that produces monoclonal antibodies for in vitro studies and diagnostic purposes.
02-Aug-2004 - Despite Thermo Electron reporting a Q2 revenue growth of 12 per cent, organic revenue growth declined from 5 per cent in 1Q04 to 3 per cent in the second quarter, due in part to the company's sale of its Optical Technologies division.
28-Jul-2004 - The reality of the violence of some UK animal activists became apparent after GlaxoSmithKline (GSK), Europes's biggest drug maker, warned that investment and jobs would be driven out of the country by their actions.
28-Jul-2004 - The Irish government is joining Johnson & Johnson subsidiary Centocor in a €650 million investment in a new manufacturing facility, it said this week. The move comes as some have questioned the country's capacity to remain a leading destination for manufacturing operations.
28-Jul-2004 - A new RFID centre designed to help pharma companies test out new track-and-trace technology to combat the issue of counterfeiting is being set up in the US by consulting firm Capgemini.
27-Jul-2004 - Bayer Biological Products has unveiled a number of new product developments as part of its major campaign to combat product tampering and counterfeiting.
27-Jul-2004 - Dutch group DSM, one of Europe's top three ingredient suppliers to drug makers, increased sales of pharma products during the second quarter but continued losses from the antibiotics market halved the Life Sciences operating profit.
26-Jul-2004 - The chief executive of leading pharmaceutical company, Astra Zeneca, has issued a bleak warning to European governments: improve the business environment, or we'll take our investment elsewhere.
26-Jul-2004 - The battle to gain control of the lucrative cholesterol-lowering drug market intensified after Merck and Schering-Plough joined forces to win Food and Drug Administration (FDA) approval for their new entrant, Vytorin.
22-Jul-2004 - Pressure on pharma ingredient supplier Lonza has continued into the first half of the year, with consistently low use of custom manufacturing capacity and weak demand for biomanufacturing contributing to a 37 per cent drop in operating income.
21-Jul-2004 - Belgian pharmaceutical and chemicals company UCB, fresh from its €2.25 billion acquisition of UK biotech Celltech, has divested its films business in a move that takes it another step closer to becoming a biopharmaceutical pure-play.
19-Jul-2004 - Major pharmaceutical and generics players are continuing to invest in plants for the production of active pharmaceutical ingredients, with Pfizer, Ivax, Berlex and Protein Design Labs all announcing new ventures in the last few days.
19-Jul-2004 - Roche is to sell its consumer health business to Germany's Bayer for €2.38 billion (SF3.6 billion) in cash, the company said today.
19-Jul-2004 - Dutch pharmaceuticals and chemicals group Akzo Nobel has reported a small decline in sales in the first half of the year, although the cost of ongoing restructuring caused net earnings to slump by nearly a quarter to €245 million.
19-Jul-2004 - The drive towards achieving better energy efficiency in UK manufacturing was given fresh impetus this week following the latest government spending review, writes Anthony Fletcher.
15-Jul-2004 - The European Union is sponsoring a new initiative aimed at producing pharmaceuticals in genetically modified crop plants such as maize, and hopes to start the first clinical trials of a product by 2009. But the news has been met with dismay by environmentalist groups, alarmed that the GM traits could find their way into the food chain.
12-Jul-2004 - A case currently going through the European Court of Justice could have worrying implications for companies that use reformulation and drug delivery as a way to extend the patented lifespan of their drugs.
12-Jul-2004 - A new Sino-American joint venture for manufacturing pharmaceuticals, HBBenda, has started operations in Guangshui, China, after being granted Good Manufacturing Practice (GMP) approval.
09-Jul-2004 - The US Food and Drug Administration claims drug companies have violated government law by failing to disclose the existence of clinical trials to a government database, writes Wai Lang Chu.